ArticleAging clinical and experimental research2025
Synergistic effects of diabetes and sarcopenic obesity on cardiovascular disease risk in middle-aged and elderly Chinese adults: a large-scale prospective cohort study.
Article in Aging clinical and experimental research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Association between impaired peripheral thyroid hormone sensitivity and coronary heart disease in type 2 diabetes: the potential mediating role of albumin.Frontiers in endocrinology · 2026Article
- Sport-specific adaptations in body composition and vascular function: a comparative study of swimmers, tennis players, and wrestlers.Frontiers in sports and active living · 2026Article
- Sedentary behavior and type 2 diabetes in community-dwelling middle-aged and older adults: indirect cross-sectional correlation of sarcopenic obesity.Frontiers in endocrinology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
backgroundDiabetes mellitus and sarcopenic obesity are increasingly prevalent conditions in aging populations, both independently associated with elevated cardiovascular disease risk. However, their synergistic effects on cardiovascular outcomes in Asian populations remain poorly understood. This study aimed to evaluate the individual and combined impacts of diabetes and sarcopenic obesity on cardiovascular disease risk in middle-aged and elderly Chinese adults.
methodsWe conducted a prospective cohort analysis using data from the China Health and Retirement Longitudinal Study (CHARLS). A total of 10,478 participants without baseline cardiovascular disease (5,122 men and 5,356 women; mean age 58.77 ± 9.24 years) were followed for 9 years (2011-2020). Participants were categorized into four groups: neither condition, diabetes alone, sarcopenic obesity alone, and both conditions. Cardiovascular disease events were identified through physician-diagnosed reports. Cox proportional hazards models were used to estimate hazard ratios (HRs) with 95% confidence intervals (CIs), adjusting for demographic, lifestyle, and clinical covariates.
resultsDuring 9 years of follow-up, 2,443 participants (23.3%) developed cardiovascular disease. Compared to participants with neither condition, the multivariable-adjusted HRs for cardiovascular disease were 1.11 (95% CI: 0.96-1.29) for diabetes alone, 1.05 (95% CI: 0.94-1.17) for sarcopenic obesity alone, and 1.34 (95% CI: 1.10-1.63, P = 0.004) for both conditions combined. The cumulative incidence of cardiovascular disease was significantly higher in the combined group (39.0%) compared to the control group (24.4%), diabetes alone (31.6%), and sarcopenic obesity alone (27.3%). Similar patterns were observed for stroke and cardiac events separately.
conclusionsThe coexistence of diabetes and sarcopenic obesity synergistically increases cardiovascular disease risk beyond the effects of either condition alone in Chinese adults. These findings highlight the importance of comprehensive screening and integrated management strategies for individuals with both conditions to prevent cardiovascular complications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.